期刊文献+

食管癌TDLN细胞对食管癌裸鼠移植瘤的体内抑瘤作用 被引量:3

Tumor-inhibition effect of esophageal carcinoma TDLN cell on the nude mice baring transplantable tumor of esophageal carcinoma in vivo
下载PDF
导出
摘要 目的探讨肿瘤引流区淋巴结细胞对食管癌裸鼠移植瘤的体内杀伤作用,为其临床应用提供依据。方法将30只食管癌移植瘤裸鼠模型随机分为对照组、IL-2组、LAK组、I-TDLN组及G-TDLN组。分别予生理盐水、IL-2、LAK细胞及体外培养的I-TDLN、G-TDLN细胞局部注射干预。分别于干预后1、2、3、4周测定各组肿瘤抑制率;干预后4周测定各组肿瘤细胞凋亡率;观察肿瘤组织病理学变化。结果 TDLN组各时点肿瘤抑制率均明显高于对照组、IL-2组及LAK组,G-TDLN组高于I-TDLN组(P均<0.05),各组肿瘤抑制率均逐渐升高,于第3周达高峰;对照组、IL-2组、LAK组、I-TDLN组、G-TDLN组细胞凋亡率依次升高,P均<0.05。LAK组及TDLN组肿瘤组织均有T淋巴细胞和DC浸润,但TDLN组明显多于LAK组。结论体外培养的食管癌TDLN细胞在体内可抑制食管癌移植瘤生长,其机制为直接杀伤肿瘤细胞并诱导肿瘤细胞凋亡。本研究为食管癌TDLN细胞用于临床食管癌的细胞免疫治疗提供了理论依据。 ObjectiveTo study the in vivo tumor-inhibition effects of tumor-draining lymph node(TDLN)on tumor-baring nude mice,so as to provide basis for its clinical application.MethodsThirty tumor-baring nude mice model were randomized into control group,IL-2 group,LAK group,I-TDLN group and G-TDLN group.Then were injected with NS,IL-2,LAK cell and I-TDLN,G-TDLN cell cultured in vitro,respectively.The tumor inhibition ratio(TIR) was evaluated 1,2,3,4 week after injection;the apoptosis ratio of tumor cell was measured in the 4th week;the histopathological changes of tumor were observed.ResultsThe TIR of I-TDLN group was significantly greater than that in LAK group,IL-2 group and control group,but which of the G-TDLN group was greater than that of I-TDLN group(P0.05).The TIR of each group increased gradually until the 3th week.The apoptosis ratio of the control group,IL-2 group,LAK group,I-TDLN group,G-TDLN group increased gradually(all P0.05).T lymphocyte and DC infiltration were found in the LAK group and TDLN group,and which was even apparent in TDLN group.ConclusionsTDLN cells cultured in vitro can inhibit the growth of transplantable tumor of esophageal carcinoma,the mechanism maybe kill tumor cells and induce its apoptosis.This study provides theoretical basis for the cellular immunotherapy on esophageal carcinoma by TDLN cell.
出处 《山东医药》 CAS 北大核心 2011年第7期1-3,共3页 Shandong Medical Journal
基金 河北省医学科学研究重点课题项目(20090519) 河北省普通高等学校强势特色学科肿瘤学建设经费资助项目(冀教高[2005]52号)
关键词 食管癌 裸鼠 肿瘤引流淋巴结 树突状细胞 T淋巴细胞 esophageal carcinoma nude mice tumor-draining lymph nodes dendritic cells T lymphocytes
  • 相关文献

参考文献10

  • 1桑玫,陈建华,刘海龙.食管癌术后复发的治疗结果[J].中国癌症杂志,2000,10(5):413-415. 被引量:8
  • 2Mayordomo JI, Zorina T, Storkus WJ, et al. Bone marrow-derived dendritic cells serve as potent adjuvants for peptide-based antitumor vaccines[J]. Stem Ceils, 1997, 15(2) : 94-103.
  • 3Yamanaka R, Zullo SA, Ramsey J, et al. Marked enhancement of antitumor immune in mouse brain tumor models by genetically mod- ified dendritic cells producing Semliki Forest virus-mediated interlekin-12 [J]. Neurasurvy, 2002,97 (3) : 611-618.
  • 4Carriere V, Coliddon R, Jiguet-Jiglaire C, et al. Cancer cells regulate lymphocyte recruitment and leukocyte- endothelium interaclions in the tumor-draining lymph node[ J ]. Cancer Res, 2005, 65 (24) : 11639-11648.
  • 5Kaeani L, Wurm M, Schennach H, et al. Immuno- suppressive effects of soluble factors secreted by head and neck squamous cell carcinoma on dendritic cells and T lymphocytes [ J ]. Oral Oncol, 2003, 39(7) : 672-679.
  • 6Cohen PA, Peng L, Kjaergaard J, et al. T-cell adoptive therapy of tumors : mechanisms of improved therapeutic performance [ J ]. Crit Rev Immunol, 2001,21(13): 215-248.
  • 7金鹰,唐玫,李国明.实用淋巴细胞培养技术[J].激光生物学报,2000,9(1):75-78. 被引量:20
  • 8李秋平,封志纯.细胞因子与树突状细胞分化诱导[J].国外医学(肿瘤学分册),2004,31(10):742-744. 被引量:3
  • 9Sabel MS, Arora A, Su G, et al. Adoptive immunotherapy of breast cancer with lymph node cells primed by cryoablation of the primary tumor [ J ]. Cryobiology, 2006, 53 (3) :360-366.
  • 10Chapoval AL, Tamada K, Chen L. In vitro growth inhibition of a broad spectrum of tumor cell lines by activated human dendrifie eells[J]. Blood. 2000. 95(7): 2346-2351.

二级参考文献21

  • 1陈建华,卫功铨,邵令方,高宗人,许金良,陈明耀.食管癌颈部、胸内吻合术疗效对比观察及生活质量评价[J].中华肿瘤杂志,1996,18(2):131-133. 被引量:60
  • 2Tang M,华南师范大学学报,1998年,4期,63页
  • 3Tang M,济南大学学报,1998年,5期,93页
  • 4Yan J,Experimental Technology Application Modern Microbiology(Chinese),1997年
  • 5Wu L N,The study of the lectin from plants by ionexchang cellulose( In Chinese),1996年,2期,64页
  • 6Cai W Q,Practical Immunocytochemistry Molecular Hybridization Technology(Chinese),1994年
  • 7Zhu H W,The Histology(In Chinese),1979年
  • 8Morisaki T, Matsumoto K, Onishi H, et al. Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients:rationale, current progress, and perspectives. Hum Cell, 2003,16 (4): 175-182.
  • 9Santini SM, Belardelli F. Advances in the use of dendritic cells and new adiuvants for the development of therapeutic vaccines. Stem Cells,2003,21 (4) :495-505.
  • 10Felazzo G, Wesa A, Wei WZ, et al. Dendtitic cells generated either from CD34 + progenitor cells or from monocytes differ in their ability to activate antigen-specific CD8 + T cells. J Immunol, 1999,163 (7):35597 -35604.

共引文献27

同被引文献14

  • 1路平,梁秋冬,牛红蕊,苗战会,刘晶,李小瑞.单药每周紫杉醇同步放疗治疗中晚期老年或低生活状态食管癌42例临床观察[J].实用肿瘤杂志,2007,22(1):61-63. 被引量:8
  • 2Black MM,Kerpe S,Speer FD. Lymph node structure in patientswith cancer of the breast [J]. Am J Path,1953 ,24(5) : 505 -521.
  • 3Sven L,Carsten K,Giuseppe P,et al. IL -2 and CD25 dependentimmunoregulatory mechanisms in the homeostasis of T - cell subsets[J]. J Allergy and Clin Immunol,2009,123(4) :758 -762.
  • 4Morris A,Vetto JT,Ramstad T,et al. Induction of anti - mammarycancer immunity by engaging the OX - 40 receptor in vivo [ J ].Breast Cancer Res Treat,2001,67:71 -80.
  • 5Ghosh AK,Moore M,Stree Ta J,et al. Expression of HLA - D sub-region products on human colorectal carcinoma[ J]. Int J Cancer,1986,38(4) :459 -464.
  • 6Lovig T,Andersen SN,Thorstensen L,et ai. Strong HLA - DR ex-pression in microsatellite stable carcinomas of the large bowel is as-sociated with good prognosis[ J]. Br J Cancer,2002,87(7) :756 -762.
  • 7Neuner G, Patel A , Sunlharalingani M. Chemoradiotherapy for e-sophag('al cancer [ J ]. Gastrointest Cancer Res, 2009 , 3 ( 2 ) : 57-65.
  • 8刘燕,牛力,刘静.HLA-DR的多态性及研究进展[J].九江学院学报(自然科学版),2010,23(2):98-100. 被引量:2
  • 9郑志范,苏华芳,邹燕,彭振,吴式琇.microRNA在食管癌放射抵抗细胞表达谱研究[J].中华医学杂志,2011,91(9):639-642. 被引量:17
  • 10张思维,张敏,李光琳,魏文强,孟凡书,刘志才,郑荣寿,李霓,陈万青.2003~2007年中国食管癌发病与死亡分析[J].中国肿瘤,2012,21(4):241-247. 被引量:222

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部